| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |